Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0020
+0.0001 (4.21%)
Oct 20, 2025, 3:04 PM EDT
Halberd Market Cap
Halberd has a market cap or net worth of $1.4 million as of October 20, 2025. Its market cap has decreased by -55.05% in one year.
Market Cap
1.40M
Enterprise Value
n/a
Revenue
6.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 1.40M, a decrease of -46.26%. That is a compound annual growth rate of -3.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 20, 2025 | 1.40M | -44.94% |
Dec 31, 2024 | 2.54M | -11.40% |
Dec 29, 2023 | 2.87M | -4.05% |
Dec 30, 2022 | 2.99M | -62.35% |
Dec 31, 2021 | 7.95M | -4.69% |
Dec 31, 2020 | 8.34M | 1,228.60% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Glass House Brands | 671.98M |
Elite Pharmaceuticals | 660.06M |
Veradigm | 517.28M |
Northwest Biotherapeutics | 347.69M |
CytoDyn | 336.10M |
Nika Pharmaceuticals | 333.67M |
Silence Therapeutics | 307.02M |
American Oncology Network | 277.57M |